Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Phase I/II GBM radiodynamic therapy trial using oral 5-ALA

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Feb 11, 2024 2:45am

226 Views

Post# 35874241

RE:Phase I/II GBM radiodynamic therapy trial using oral 5-ALA

A GBM study would be sweet to get going. Any success there and things should run wild. I suspect it will be a while until that happens though. But you never know, the BTD could change many things if/when it arrives. Hope the latest money raise can last until then..

I got a friend at work to buy Theralase at 17 cents. Now, since it is at 20 cents, he wants to buy more. I told him not to tempt his fate, lol. But he seemed keen on it.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks